Lattice Semicond (NASDAQ:LSCC)’s share price soared 1.74% or 0.1 to reach at $5.86 during previous trading session. A total of 2 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.21 Million shares. Lattice Semicond (NASDAQ:LSCC) has a market capitalization of $711.46 Million and most recently 121.41 Million outstanding shares have been calculated.

According to sentiments of 4 analysts the mean estimates of short term price target for the company’s stock is marked at $6.25. The most optimistic analyst sees the stock reaching $7 while the most conventional predicts the target price at $5.5.

In terms of Buy/Sell recommendations, 3 analysts have a consensus rating of 2.33 on the shares of Lattice Semicond (NASDAQ:LSCC). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 3 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Lattice Semicond (NASDAQ:LSCC)’s distance from 20 day simple moving average is -0.021 along with distance from 50 day simple moving average of 6.03 whereas its distance from 200 day simple moving average is 6.12. Lattice Semicond (NASDAQ:LSCC)’s price distance from 52-week high is -22.38 and from 52-week low is 16.04. The stock hit its 52-week high price on 03/24/17, and 52-week low price on 09/26/17. The stock’s 52-week price fluctuated within the range of $7.55 – $5.05.

Lattice Semicond (NASDAQ:LSCC)’s shares climbed 3.35% in the past week and plunged -4.4% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -13.31% while its year to date performance is at -20.38%.

While taking a glance at financials, we can look at a number of key indicators. Lattice Semicond (NASDAQ:LSCC) has a Return on Assets (ROA) of -10.1. The company currently has a Return on Equity (ROE) of -28.2 and a Return on Investment (ROI) of -6.1. Average true range (ATR-14) of the company sets at 0.2, along with its weekly and monthly volatility of 2.07% and 3.51% respectively. Relative strength index (RSI-14) for Lattice Semicond (NASDAQ:LSCC) is at 47.99. Beta value of the stock stands at 1.57.

The company’s price to free cash flow for trailing twelve months is 16.51. Its quick ratio for most recent quarter is 1.6 along with current ratio for most recent quarter of 2.2. Total debt to equity ratio of Lattice Semicond (NASDAQ:LSCC) for most recent quarter is 1.39 whereas long term debt to equity ratio for most recent quarter is 1.28.

Shares of Endocyte Inc (NASDAQ:ECYT) plunged -4.34% or -0.2 to reach at $4.41 during previous trading session. Endocyte Inc (NASDAQ:ECYT) has a market capitalization of $183.06 Million and most recently 41.51 Million outstanding shares have been calculated. A total of 1.97 Million shares exchanged hands, whereas the company’s average trading volume stands at 3.22 Million shares.

According to 1 analysts Endocyte Inc (NASDAQ:ECYT)’s price will reach at $7 during 52 weeks. Stock’s minimum price target estimates has been figured out at $7 while the maximum price target forecast is established at $7.

According to the recommendations from 2 analysts stock has mean rating of 2 on the shares of Endocyte Inc (NASDAQ:ECYT). Out of rating recommendations 1 have given the stock a Buy while 0 recommend the stock as Outperform. 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Endocyte Inc (NASDAQ:ECYT) slipped -10.73% in the past week and plunged -6.57% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 177.36% while its year to date performance is at 72.94%.

Endocyte Inc (NASDAQ:ECYT)’s 52-week price fluctuated within the range of $6.55 – $1.17. Its price distance from 52-week high is -32.67 and from 52-week low is 276.92. The stock hit its 52-week high price on 10/03/17, and 52-week low price on 08/21/17. Endocyte Inc (NASDAQ:ECYT)’s distance from 20 day simple moving average is-0.088 along with distance from 50 day simple moving average of 4.82 whereas its distance from 200 day simple moving average is 2.76.

Total debt to equity ratio of Endocyte Inc (NASDAQ:ECYT) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 24 along with current ratio for most recent quarter of 24.

Average true range (ATR-14) of the company sets at 0.35, along with its weekly and monthly volatility of 6.83% and 7.15% respectively. Relative strength index (RSI-14) for Endocyte Inc (NASDAQ:ECYT) is at 41.46. Beta value of the stock stands at 2.27. Endocyte Inc (NASDAQ:ECYT) has a Return on Assets (ROA) of -45.6. The company currently has a Return on Equity (ROE) of -47.8 and a Return on Investment (ROI) of 0.